Antifungal Drugs Market 2020-2024

Global Antifungal Drugs Market 2020-2024

The publisher has been monitoring the antifungal drugs market and it is poised to grow by USD 2.50 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period. The reports on antifungal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of fungal infections, emerging new targets for the treatment of resistant fungal infections and an increase in antifungal research funding. In addition, the increasing prevalence of fungal infections is anticipated to boost the growth of the market as well.

The antifungal drugs market analysis includes the route of administration segment and geographical landscapes.

The antifungal drugs market is segmented as below:

By Route of administration

• Topical
• Oral
• Parenteral

By Geographical Landscapes

• North America
• Europe
• Asia
• ROW

This study identifies the use of antifungal combinations as one of the prime reasons driving the antifungal drugs market growth during the next few years. Also, use of immunomodulatory therapies for fungal infection and increasing awareness about fungal infections will lead to sizable demand in the market.

The antifungal drugs market covers the following areas:

• Antifungal drugs market sizing
• Antifungal drugs market forecast
• Antifungal drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antifungal drugs market vendors that include Abbott Laboratories, Bayer AG, Eisai Co. Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., and Sanofi. Also, the antifungal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.